• Cefoperazone Sodium Salt: Optimizing Antibacterial Activity

  2026-07-14

  Cefoperazone sodium salt stands out as a β-lactamase-stable, broad-spectrum cephalosporin, enabling reliable in vitro and in vivo studies targeting gram-negative bacilli and resistant pathogens. This guide translates key findings into actionable workflows, troubleshooting strategies, and comparative insights—empowering researchers to refine antimicrobial assays and infection models with confidence.

• Advancing α2-Adrenergic Research: Practical Guide to 5-bromo

  2026-07-14

  Explore the rigorous use of 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine as a selective α2-adrenergic receptor agonist for immune rejection modulation in post-surgery osteosarcoma recurrence research. This article delivers technical guidance, protocol insights, and a critical analysis of recent innovations for advanced receptor signaling studies.

• Resveratrol Enhances Cholesterol Efflux in Dendritic Cells t

  2026-07-13

  This study uncovers how resveratrol promotes cholesterol efflux from dendritic cells, regulating costimulation signals and T-cell activation in a mouse model of atherosclerosis. The findings provide mechanistic insight into resveratrol’s dual roles in lipid metabolism and immune modulation, with implications for targeting inflammatory cardiovascular diseases.

• α-Bungarotoxin in Experimental Necroptosis: A Gateway for Pl

  2026-07-13

  Explore how α-Bungarotoxin enables precision nicotinic receptor blockade and dissects cholinergic neurotransmission inhibition in advanced neurotoxicity and placental necroptosis models. This in-depth analysis reveals unique experimental strategies and translational insights for neuroscience research tools.

• Regorafenib (BAY 73-4506) Workflows in Tumor Angiogenesis Re

  2026-07-12

  Regorafenib (BAY 73-4506) empowers researchers to dissect complex tumor biology and angiogenesis with precision, thanks to its multikinase inhibition profile. This guide translates the latest mechanistic findings into actionable protocols and troubleshooting strategies for advanced cancer biology research.

• Neuromedin S (rat): Technical Guide for GPCR Signaling Resea

  2026-07-10

  Neuromedin S (rat) provides researchers with a chemically defined peptide agonist for the controlled activation of neuromedin U receptor signaling pathways in rat GPCR/G protein studies. This product is not intended for diagnostic or therapeutic use and is best applied in laboratory workflows focused on mechanistic research of physiological signaling.

• Phenothiazines Drive Macrophage Antibacterial Activity via R

  2026-07-09

  The referenced study demonstrates that phenothiazines, including perphenazine, significantly enhance the antibacterial capabilities of macrophages by inducing reactive oxygen species (ROS) and autophagy. These findings advance host-directed therapy strategies, offering a promising alternative for combating antibiotic-resistant intracellular bacterial infections.

• Hypoxia-Activated Photomolecular Glues Target Cyclin K in Ca

  2026-07-09

  This study introduces a hypoxia-activated photomolecular glue, BNNC, that synergistically degrades Cyclin K and delivers phototherapy for selective tumor targeting. The approach enhances antitumor efficacy while minimizing off-target toxicity, offering a promising strategy for improving molecular glue-based cancer therapies.

• High-Throughput BBB Model: Integrating MDR1 Cells and Lysoso

  2026-07-08

  This study introduces a robust high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, incorporating lysosomal trapping correction to enhance predictive accuracy for CNS drug permeability. The model enables efficient discrimination between passive diffusion, transporter-mediated efflux, and lysosomal sequestration, significantly streamlining early-stage CNS drug screening.

• 3-Deazaadenosine Hydrochloride: Reliable SAHH Inhibitor for

  2026-07-08

  This article explores how 3-Deazaadenosine hydrochloride (SKU B8470) addresses core laboratory challenges in cell proliferation, viability, and methylation-driven research. Using scenario-driven Q&A, it demonstrates evidence-based best practices for reproducibility and assay optimization with this selective S-adenosylhomocysteine hydrolase inhibitor.

• GW 4869 Hydrochloride Hydrate: Exosome Inhibition & Research

  2026-07-07

  GW 4869 hydrochloride hydrate is a potent, cell-permeable inhibitor of exosome biogenesis via selective neutral sphingomyelinase (N-SMase) inhibition. This compound modulates sphingolipid metabolism and ceramide production in low micromolar ranges, providing a precise tool for dissecting extracellular vesicle dynamics and cell signaling in disease models.

• Masitinib (AB1010): Technical Guidance for KIT/PDGFR Inhibit

  2026-07-07

  Masitinib (AB1010) is a selective tyrosine kinase inhibitor optimized for research targeting KIT, PDGFRα, and PDGFRβ signaling, suitable for cancer biology, mastocytosis, and inflammatory disease workflows. It is best used in DMSO-based protocols requiring high specificity and is not compatible with aqueous or ethanol-based assays or studies demanding broad kinase inhibition.

• CDK9 Inhibitor (A3294): Selective Transcription Elongation B

  2026-07-06

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor designed for precise targeting of cyclin dependent kinase 9, supporting research into transcription elongation and HIV-1 propagation inhibition. It should not be used in studies requiring pan-CDK inhibition or protocols needing long-term storage of active solutions.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-07-06

  Wang et al. (2024) uncover a METTL16-SENP3-LTF signaling axis that confers ferroptosis resistance and promotes tumorigenesis in hepatocellular carcinoma (HCC). Their integrative approach highlights how RNA m6A modification and iron metabolism intersect to drive HCC progression, indicating potential molecular targets for sensitizing HCC to ferroptosis-based therapies.

• Isoprinosine in Immunotherapy: Protocols and HHV-1 Insights

  2026-07-05

  Isoprinosine (inosine pranobex) delivers dual-action immunomodulation and direct viral inhibition, uniquely supporting experimental workflows targeting herpesvirus and acute respiratory infections. This guide translates the latest mechanistic findings—like CLCC1’s role in viral egress—into actionable protocols and troubleshooting strategies for advanced translational research.

15459 records 1/1031 page Next 12345 下5页 Last page